Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
59
ZBIO Quote, Financials, Valuation and Earnings
Last price:
$43.29
Seasonality move
:
-1.59%
Day range:
$42.51 - $44.60
52-week range:
$5.83 - $44.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
120.60x
P/B ratio:
9.19x
Volume:
130.9K
Avg. volume:
357.5K
1-year change:
342.77%
Market cap:
$1.8B
Revenue:
$5M
EPS (TTM):
-$4.53
Earnings Data
Next earnings date for ZBIO
Mar 17
2026
Most recent earnings per share
-$1.22
Missed by $0.37
(Nov 12/2025)
Consensus Estimate
-$0.85
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ZBIO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/17/2026 | Q4 | $28.8M | -- | -- | -$1.19 | -- |
| 11/12/2025 | Q3 | $10M | -- | -$1.22 | -$0.85 | -$0.37 |
| 08/12/2025 | Q2 | $1.3M | -- | -$1.25 | -$1.06 | -$0.19 |
| 05/08/2025 | Q1 | $1.7M | $10M | -$0.80 | -$1.03 | $0.23 |
| 03/14/2025 | Q4 | -- | $5M | -$1.26 | -$1.02 | -$0.24 |
| 11/12/2024 | Q3 | -- | -- | -$0.92 | -$9.30 | $8.38 |
| 06/30/2024 | Q2 | -- | -- | -$0.99 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.73 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.16 | -- | -- |
| 09/30/2023 | Q3 | -- | $50M | $0.85 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.76 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.50 | -- | -- |
Zenas BioPharma, Inc. Earnings Questions
-
How Much did Zenas BioPharma, Inc. Generate in Revenue Last Quarter?
Zenas BioPharma, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Zenas BioPharma, Inc. Beat Earnings Last Quarter?
Zenas BioPharma, Inc. announced earnings per share of -$1.22 which represents a miss of analyst forecast a -$0.85 per share.
-
Is Zenas BioPharma, Inc. Profitable?
Zenas BioPharma, Inc. reported -$11K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Zenas BioPharma, Inc. EPS Next Year?
Zenas BioPharma, Inc.'s earnings are forecast to decrease from -$3.76 per share to -$7.04 per share next year representing a decrease of -16.87%.
-
When is Zenas BioPharma, Inc.'s Earnings Date?
Zenas BioPharma, Inc.'s next earnings date is March 17, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
